BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $4.14B (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 41.4%

Value $1.713B Shares 60,632,356 Share Price $28.26 Est. Cost/Share — Unrealized @ Report Date —

— DIVERSEY HLDGS LTD 27.8%

Value $1.15B Shares 236,561,159 Share Price $4.86 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 27.7%

Value $1.148B Shares 49,064,576 Share Price $23.40 Est. Cost/Share — Unrealized @ Report Date —

AVAH AVEANNA HEALTHCARE HLDGS INC 3.0%

Value $122M Shares 81,600,880 Share Price $1.50 Est. Cost/Share — Unrealized @ Report Date —

ADV ADVANTAGE SOLUTIONS INC 0.1%

Value $6.156M Shares 2,890,000 Share Price $2.13 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1.713B	41.4%	$28.26	—	—	COM	15678U128
—	DIVERSEY HLDGS LTD	236,561,159	$1.15B	27.8%	$4.86	—	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$1.148B	27.7%	$23.40	—	—	COM	86881A100
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$122M	3.0%	$1.50	—	—	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$6.156M	0.1%	$2.13	—	—	COM CL A	00791N102